A detailed history of Truist Financial Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Truist Financial Corp holds 8,003 shares of IONS stock, worth $317,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,003
Previous 9,499 15.75%
Holding current value
$317,799
Previous $411,000 7.3%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 20, 2024

SELL
$36.45 - $47.7 $54,529 - $71,359
-1,496 Reduced 15.75%
8,003 $381,000
Q1 2024

May 10, 2024

SELL
$42.03 - $53.55 $19,585 - $24,954
-466 Reduced 4.68%
9,499 $411,000
Q4 2023

Feb 02, 2024

BUY
$43.39 - $51.63 $432,381 - $514,492
9,965 New
9,965 $504,000
Q3 2022

Oct 26, 2022

SELL
$36.54 - $48.66 $582,593 - $775,835
-15,944 Reduced 71.29%
6,420 $284,000
Q2 2022

Jul 22, 2022

SELL
$31.71 - $43.0 $282,409 - $382,958
-8,906 Reduced 28.48%
22,364 $828,000
Q1 2022

Apr 22, 2022

BUY
$29.88 - $37.04 $9,950 - $12,334
333 Added 1.08%
31,270 $1.16 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $1,024 - $1,404
-40 Reduced 0.13%
30,937 $941,000
Q3 2021

Nov 05, 2021

BUY
$33.54 - $40.55 $197,081 - $238,271
5,876 Added 23.41%
30,977 $1.04 Million
Q2 2021

Aug 16, 2021

BUY
$34.54 - $47.25 $118,713 - $162,398
3,437 Added 15.87%
25,101 $1 Million
Q1 2021

May 17, 2021

BUY
$42.51 - $63.78 $442,444 - $663,822
10,408 Added 92.47%
21,664 $974,000
Q4 2020

Nov 19, 2021

SELL
$45.3 - $60.27 $438,730 - $583,714
-9,685 Reduced 46.25%
11,256 $636,000
Q4 2020

Feb 18, 2021

BUY
$45.3 - $60.27 $429,353 - $571,239
9,478 Added 82.68%
20,941 $1.18 Million
Q3 2020

Nov 13, 2020

SELL
$47.45 - $62.95 $18,600 - $24,676
-392 Reduced 3.31%
11,463 $545,000
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $8,573 - $11,172
183 Added 1.57%
11,855 $698,000
Q1 2020

May 15, 2020

SELL
$41.6 - $63.4 $66,934 - $102,010
-1,609 Reduced 12.12%
11,672 $551,000
Q4 2019

Feb 14, 2020

BUY
$53.85 - $65.27 $715,181 - $866,850
13,281 New
13,281 $802,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.